Selected research
Market Outlook & Growth Opportunities
Global Chicken Medicine and Vaccines Market Outlook and Growth Opportunities 2026
Market perspective
The global Chicken Medicine and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Chicken Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Chicken Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chicken Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Chicken Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Chicken Medicine and Vaccines market include CAVAC, CEVA, DHN, Elanco (Lohmann), FATRO, Merial, QYH Biotech, Ringpu Biology and Vaksindo, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Chicken Medicine and Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Chicken Medicine and Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Chicken Medicine and Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chicken Medicine and Vaccines market.
Chicken Medicine and Vaccines Segment by Company
CAVAC
CEVA
DHN
Elanco (Lohmann)
FATRO
Merial
QYH Biotech
Ringpu Biology
Vaksindo
Yebio
Zoetis
ChengDu Tecbond
Merck Animal Health
Harbin Veterinary Research Institute
Chicken Medicine and Vaccines Segment by Type
Medicine
Vaccines
Chicken Medicine and Vaccines Segment by Application
Farm
Government
Chicken Medicine and Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Chicken Medicine and Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Chicken Medicine and Vaccines key companies, revenue, market share, and recent developments.
3. To split the Chicken Medicine and Vaccines breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Chicken Medicine and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Chicken Medicine and Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Chicken Medicine and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chicken Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chicken Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chicken Medicine and Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chicken Medicine and Vaccines industry.
Chapter 3: Detailed analysis of Chicken Medicine and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Chicken Medicine and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Chicken Medicine and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Vaccines
Applications
- Farm
- Government
Companies covered
- CAVAC
- CEVA
- DHN
- Elanco (Lohmann)
- FATRO
- Merial
- QYH Biotech
- Ringpu Biology
- Vaksindo
- Yebio
- Zoetis
- ChengDu Tecbond
- Merck Animal Health
- Harbin Veterinary Research Institute
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Chicken Medicine and Vaccines Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Chicken Medicine and Vaccines Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Chicken Medicine and Vaccines Market Dynamics
- 2.1 Chicken Medicine and Vaccines Industry Trends
- 2.2 Chicken Medicine and Vaccines Industry Drivers
- 2.3 Chicken Medicine and Vaccines Industry Opportunities and Challenges
- 2.4 Chicken Medicine and Vaccines Industry Restraints
3 Chicken Medicine and Vaccines Market by Company
- 3.1 Global Chicken Medicine and Vaccines Company Revenue Ranking in 2025
- 3.2 Global Chicken Medicine and Vaccines Revenue by Company (2021-2026)
- 3.3 Global Chicken Medicine and Vaccines Company Ranking (2024-2026)
- 3.4 Global Chicken Medicine and Vaccines Company Manufacturing Base and Headquarters
- 3.5 Global Chicken Medicine and Vaccines Company Product Type and Application
- 3.6 Global Chicken Medicine and Vaccines Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Chicken Medicine and Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Chicken Medicine and Vaccines Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Chicken Medicine and Vaccines Market by Type
- 4.1 Chicken Medicine and Vaccines Type Introduction
- 4.1.1 Medicine
- 4.1.2 Vaccines
- 4.2 Global Chicken Medicine and Vaccines Sales Value by Type
- 4.2.1 Global Chicken Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Chicken Medicine and Vaccines Sales Value by Type (2021-2032)
- 4.2.3 Global Chicken Medicine and Vaccines Sales Value Share by Type (2021-2032)
5 Chicken Medicine and Vaccines Market by Application
- 5.1 Chicken Medicine and Vaccines Application Introduction
- 5.1.1 Farm
- 5.1.2 Government
- 5.2 Global Chicken Medicine and Vaccines Sales Value by Application
- 5.2.1 Global Chicken Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Chicken Medicine and Vaccines Sales Value by Application (2021-2032)
- 5.2.3 Global Chicken Medicine and Vaccines Sales Value Share by Application (2021-2032)
6 Chicken Medicine and Vaccines Regional Value Analysis
- 6.1 Global Chicken Medicine and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Chicken Medicine and Vaccines Sales Value by Region (2021-2032)
- 6.2.1 Global Chicken Medicine and Vaccines Sales Value by Region: 2021-2026
- 6.2.2 Global Chicken Medicine and Vaccines Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Chicken Medicine and Vaccines Sales Value (2021-2032)
- 6.3.2 North America Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Chicken Medicine and Vaccines Sales Value (2021-2032)
- 6.4.2 Europe Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Chicken Medicine and Vaccines Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Chicken Medicine and Vaccines Sales Value (2021-2032)
- 6.6.2 South America Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Chicken Medicine and Vaccines Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Chicken Medicine and Vaccines Country-level Value Analysis
- 7.1 Global Chicken Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Chicken Medicine and Vaccines Sales Value by Country (2021-2032)
- 7.2.1 Global Chicken Medicine and Vaccines Sales Value by Country (2021-2026)
- 7.2.2 Global Chicken Medicine and Vaccines Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.7.2 France Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.14.2 China Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.17.2 India Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 CAVAC
- 8.1.1 CAVAC Company Information
- 8.1.2 CAVAC Business Overview
- 8.1.3 CAVAC Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.1.4 CAVAC Chicken Medicine and Vaccines Product Portfolio
- 8.1.5 CAVAC Recent Developments
- 8.2 CEVA
- 8.2.1 CEVA Company Information
- 8.2.2 CEVA Business Overview
- 8.2.3 CEVA Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.2.4 CEVA Chicken Medicine and Vaccines Product Portfolio
- 8.2.5 CEVA Recent Developments
- 8.3 DHN
- 8.3.1 DHN Company Information
- 8.3.2 DHN Business Overview
- 8.3.3 DHN Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.3.4 DHN Chicken Medicine and Vaccines Product Portfolio
- 8.3.5 DHN Recent Developments
- 8.4 Elanco (Lohmann)
- 8.4.1 Elanco (Lohmann) Company Information
- 8.4.2 Elanco (Lohmann) Business Overview
- 8.4.3 Elanco (Lohmann) Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.4.4 Elanco (Lohmann) Chicken Medicine and Vaccines Product Portfolio
- 8.4.5 Elanco (Lohmann) Recent Developments
- 8.5 FATRO
- 8.5.1 FATRO Company Information
- 8.5.2 FATRO Business Overview
- 8.5.3 FATRO Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.5.4 FATRO Chicken Medicine and Vaccines Product Portfolio
- 8.5.5 FATRO Recent Developments
- 8.6 Merial
- 8.6.1 Merial Company Information
- 8.6.2 Merial Business Overview
- 8.6.3 Merial Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.6.4 Merial Chicken Medicine and Vaccines Product Portfolio
- 8.6.5 Merial Recent Developments
- 8.7 QYH Biotech
- 8.7.1 QYH Biotech Company Information
- 8.7.2 QYH Biotech Business Overview
- 8.7.3 QYH Biotech Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.7.4 QYH Biotech Chicken Medicine and Vaccines Product Portfolio
- 8.7.5 QYH Biotech Recent Developments
- 8.8 Ringpu Biology
- 8.8.1 Ringpu Biology Company Information
- 8.8.2 Ringpu Biology Business Overview
- 8.8.3 Ringpu Biology Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.8.4 Ringpu Biology Chicken Medicine and Vaccines Product Portfolio
- 8.8.5 Ringpu Biology Recent Developments
- 8.9 Vaksindo
- 8.9.1 Vaksindo Company Information
- 8.9.2 Vaksindo Business Overview
- 8.9.3 Vaksindo Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.9.4 Vaksindo Chicken Medicine and Vaccines Product Portfolio
- 8.9.5 Vaksindo Recent Developments
- 8.10 Yebio
- 8.10.1 Yebio Company Information
- 8.10.2 Yebio Business Overview
- 8.10.3 Yebio Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.10.4 Yebio Chicken Medicine and Vaccines Product Portfolio
- 8.10.5 Yebio Recent Developments
- 8.11 Zoetis
- 8.11.1 Zoetis Company Information
- 8.11.2 Zoetis Business Overview
- 8.11.3 Zoetis Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.11.4 Zoetis Chicken Medicine and Vaccines Product Portfolio
- 8.11.5 Zoetis Recent Developments
- 8.12 ChengDu Tecbond
- 8.12.1 ChengDu Tecbond Company Information
- 8.12.2 ChengDu Tecbond Business Overview
- 8.12.3 ChengDu Tecbond Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.12.4 ChengDu Tecbond Chicken Medicine and Vaccines Product Portfolio
- 8.12.5 ChengDu Tecbond Recent Developments
- 8.13 Merck Animal Health
- 8.13.1 Merck Animal Health Company Information
- 8.13.2 Merck Animal Health Business Overview
- 8.13.3 Merck Animal Health Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.13.4 Merck Animal Health Chicken Medicine and Vaccines Product Portfolio
- 8.13.5 Merck Animal Health Recent Developments
- 8.14 Harbin Veterinary Research Institute
- 8.14.1 Harbin Veterinary Research Institute Company Information
- 8.14.2 Harbin Veterinary Research Institute Business Overview
- 8.14.3 Harbin Veterinary Research Institute Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
- 8.14.4 Harbin Veterinary Research Institute Chicken Medicine and Vaccines Product Portfolio
- 8.14.5 Harbin Veterinary Research Institute Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst